Association between Adherence to SSRI Treatment and Mortality among Individuals with Metabolic Syndrome Components.

Avrahamy, Hamutal; Shoval, Gal; Hoshen, Moshe; Balicer, Ran D; Kamhi-Nesher, Shiri; Zalsman, Gil; Weizman, Abraham; Krivoy, Amir

Avrahamy, Hamutal; Shoval, Gal; Hoshen, Moshe; Balicer, Ran D; Kamhi-Nesher, Shiri; Zalsman, Gil; Weizman, Abraham; Krivoy, Amir.

Affiliation

Avrahamy H; Geha Mental Health Center, Petah-Tikva, Israel.
Shoval G; Geha Mental Health Center, Petah-Tikva, Israel.
Hoshen M; Sackler Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Israel.
Balicer RD; Clalit Research Institute, Clalit Health Services, Tel-Aviv, Israel.
Kamhi-Nesher S; Clalit Research Institute, Clalit Health Services, Tel-Aviv, Israel.
Zalsman G; Clalit Research Institute, Clalit Health Services, Tel-Aviv, Israel.
Weizman A; Public Health Department, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Krivoy A; Geha Mental Health Center, Petah-Tikva, Israel.

Pharmacopsychiatry ; 54(5): 232-239, 2021 Sep.

Article in En | MEDLINE | ID: mdl-33853176

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Diabetes Mellitus, Type 2 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacopsychiatry Year: 2021 Document type: Article Affiliation country: Israel Country of publication: Alemania

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google